New AI tool could revolutionize male fertility testing for IVF
NCT ID NCT07185984
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aims to develop and validate an artificial intelligence tool that analyzes sperm quality using microfluidic technology. Researchers will test the tool on 200 men undergoing IVF or artificial insemination. The goal is to provide a more accurate, standardized diagnosis and recommend the best treatment, potentially improving success rates compared to current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SwimCount™ Harvester microfluidic system and AI-based diagnostic tool
What this could lead to
If successful, this could lead to a more accurate, personalized way to assess male fertility and select the best IVF treatment, potentially increasing pregnancy success rates.
What could go wrong
This is an early-stage validation study with 200 participants, so the tool may not prove accurate or beneficial in real-world settings. It also relies on existing technology and may not work for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY (IVF PATIENTS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IVI Valencia
Valencia, 46015, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••